Predictors of severe adverse outcomes in febrile neutropenia of pediatric oncology patients at a single institute in Thailand

References

• Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. doi:10.3322/caac.21219.
   PubMed Web of Science ®Google Scholar
• Wiangnon S, Veerakul G, Nuchprayoon I, et al. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev. 2011;12(9):2215–2220. doi:10.7314/apjcp.2014.15.18.7989.
   PubMedGoogle Scholar
• Bate J, Ladhani S, Sharland M, et al. Infection-related mortality in children with malignancy in England and Wales, 2003–2005. Pediatr Blood Cancer. 2009;53(3):371–374. doi:10.1002/pbc.22057.
   PubMed Web of Science ®Google Scholar
• Pakakasama S, Surayuthpreecha K, Pandee U, et al. Clinical practice guidelines for children with cancer presenting with fever to the emergency room. Pediatr Int. 2011;53(6):902–905. doi:10.1111/j.1442-200X.2011.03363.x.
   PubMed Web of Science ®Google Scholar
• Inaba H, Pei D, Wolf J, et al. Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann Oncol. 2017;28(2):386–392. doi:10.1093/annonc/mdw557.
   PubMed Web of Science ®Google Scholar
• Li MJ, Chang HH, Yang YL, et al. Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: a 16-year tertiary single-institution experience. Pediatr Blood Cancer. 2017;64(10):e26535. doi:10.1002/pbc.26535.
   Web of Science ®Google Scholar
• Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19(14):3415–3421. doi:10.1200/JCO.2001.19.14.3415.
   PubMed Web of Science ®Google Scholar
• Bothra M, Seth R, Kapil A, Dwivedi SN, Bhatnagar S, Xess I. Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients. Indian J Pediatr. 2013;80(4):297–302. doi:10.1007/s12098-012-0925-3.
   PubMed Web of Science ®Google Scholar
• Park Y, Kim DS, Park SJ, et al. The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease. Leuk Res. 2010;34(3):294–300. doi:10.1016/j.leukres.2009.08.024.
   PubMed Web of Science ®Google Scholar
• Das A, Trehan A, Oberoi S, Bansal D. Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India. Pediatr Blood Cancer. 2017;64(6):e26333. doi:10.1002/pbc.26333.
   Web of Science ®Google Scholar
• The Thai Pediatric Oncology Group. National Protocol for the Treatment of Childhood Cancer 2014. Bangkok: M-Print Corporation; 2014. (in Thai)
   Google Scholar
• The Thai Pediatric Oncology Group. National Protocol for the Treatment of Childhood Cancer 2016. Bangkok: M-Print Corporation; 2016. (in Thai)
   Google Scholar
• Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34(6):730–751. doi:10.1086/339215.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Anthro for personal computers, version 3.2.2, 2011: software for assessing growth and development of the world’s children. Geneva: WHO. https://www.who.int/childgrowth/software/en/. Published 2010. Accessed December 30, 2019.
   Google Scholar
• World Health Organization. WHO AnthroPlus for personal computers manual: software for assessing growth of the world’s children and adolescents. Geneva: WHO. http://www.who.int/growthref/tools/en/. Published 2009. Accessed: December 30, 2019.
   Google Scholar
• Arif T, Phillips RS. Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer. Pediatr Blood Cancer. 2019;66(10):e27887. doi:10.1002/pbc.27887.
   PubMed Web of Science ®Google Scholar
• United Medical Education. PALS (Pediatric Advanced Life Support) algorithms. https://www.acls-pals-bls.com/algorithms/pals/. Published 2019. Accessed: March 20, 2020.
   Google Scholar
• Advanced Medical Certification. PALS (Pediatric Advanced Life Support) diagnose respiratory distress and respiratory failure. https://advancedmedicalcertification.com/lesson/diagnose-respiratory-distress-respiratory-failure-pals-online-handbook/. Published 2017. Accessed: March 20, 2020.
   Google Scholar
• Friedman ML, Nitu ME. Acute respiratory failure in children. Pediatr Ann. 2018;47(7):e268–e273. doi:10.3928/19382359-20180625-01.
   PubMed Web of Science ®Google Scholar
• Vathana N, Thitipolpun S, Buaboonnam J, Phuakpet K, Sanpakit K. Prevalence of pathogens in pediatric cancer patients with febrile neutropenia. Southeast Asian J Trop Med Public Health. 2017;48(Suppl2):151–160.
   Google Scholar
• Alam MM, Qureshi S, Matloob R, Channa Y, Shaikh AS, Mushtaq N. Prolonged febrile neutropenia: risk factors and outcome in pediatric oncology patients. Infect Dis J Pak. 2014;23(2):677–681.
   Google Scholar
• Rondinelli PI, Ribeiro Kde C, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol. 2006;28(10):665–670. doi:10.1097/01.mph.0000212996.94929.0b.
   PubMed Web of Science ®Google Scholar
• Osmani AH, Ansari TZ, Masood N, Ahmed B. Outcome of febrile neutropenic patients on granulocyte colony stimulating factor in a tertiary care hospital. Asian Pac J Cancer Prev. 2012;13(6):2523–2526. doi:10.7314/APJCP.2012.13.6.2523.
   PubMedGoogle Scholar
• Meena JP, Brijwal M, Seth R, et al. Prevalence and clinical outcome of respiratory viral infections among children with cancer and febrile neutropenia. Pediatr Hematol Oncol. 2019;36(6):330–343. doi:10.1080/08880018.2019.1631920.
   PubMed Web of Science ®Google Scholar
• Reinecke J, Lowas S, Snowden J, Neemann K. Blood stream infections and antibiotic utilization in pediatric leukemia patients with febrile neutropenia. J Pediatr Hematol Oncol. 2019;41(4):251–255. doi:10.1097/MPH.0000000000001279.
   PubMed Web of Science ®Google Scholar
• Prasad M, Chinnaswamy G, Arora B, Vora T, Hawaldar R, Banavali S. Risk predictors for adverse outcome in pediatric febrile neutropenia: single center experience from a low and middle-income country. Indian J Cancer. 2014;51(4):432–437. doi:10.4103/0019-509X.175321.
   PubMed Web of Science ®Google Scholar